Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-03 @ 8:18 AM
Study NCT ID:
NCT06863259
Status:
RECRUITING
Last Update Posted:
2025-06-13
First Post:
2025-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
Sponsor:
Children's Hospital Medical Center, Cincinnati
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IoVeX-JR-2024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None